C. Faustino

677 total citations
9 papers, 14 citations indexed

About

C. Faustino is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, C. Faustino has authored 9 papers receiving a total of 14 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in C. Faustino's work include Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). C. Faustino is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). C. Faustino collaborates with scholars based in Portugal, Belarus and United Kingdom. C. Faustino's co-authors include Javier Sabater, Nuno Sousa, Cláudia Camila Dias, Takayuki Ando, Edvard Zhavrid, Alexandra Teixeira, Wasat Mansoor, Şuayib Yalçın, Fátima Carneiro and Aliaksandr Prokharau and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

C. Faustino

8 papers receiving 14 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Faustino Portugal 3 10 7 6 4 3 9 14
Catarina Baía Portugal 3 6 0.6× 6 0.9× 4 0.7× 7 1.8× 2 0.7× 9 20
Flora Li Tze Chong Malaysia 3 8 0.8× 9 1.3× 3 0.5× 5 1.3× 2 0.7× 5 22
T AlSumai Saudi Arabia 3 8 0.8× 10 1.4× 8 1.3× 5 1.3× 6 2.0× 4 26
Behrad Barmayehvar United Kingdom 3 6 0.6× 9 1.3× 6 1.0× 9 2.3× 3 1.0× 7 20
Artem Poltoratsky Australia 2 7 0.7× 8 1.1× 2 0.3× 2 0.5× 3 1.0× 2 10
Laurent Brureau France 2 8 0.8× 5 0.7× 4 0.7× 2 0.5× 2 0.7× 2 11
I Salgado Chile 3 8 0.8× 5 0.7× 3 0.5× 10 2.5× 3 1.0× 3 20
Sara Corral Moreno Spain 3 14 1.4× 8 1.1× 3 0.5× 8 2.0× 5 1.7× 8 21
Gonçalo Guidi Portugal 2 5 0.5× 7 1.0× 5 0.8× 6 1.5× 1 0.3× 9 17
Eunice Spengler Argentina 2 5 0.5× 9 1.3× 6 1.0× 2 0.5× 3 1.0× 4 15

Countries citing papers authored by C. Faustino

Since Specialization
Citations

This map shows the geographic impact of C. Faustino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Faustino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Faustino more than expected).

Fields of papers citing papers by C. Faustino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Faustino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Faustino. The network helps show where C. Faustino may publish in the future.

Co-authorship network of co-authors of C. Faustino

This figure shows the co-authorship network connecting the top 25 collaborators of C. Faustino. A scholar is included among the top collaborators of C. Faustino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Faustino. C. Faustino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Martins, Diana, et al.. (2022). Evaluating the Optimal Sequence of Treatment With EGFR Inhibitors and Bevacizumab in RAS Wild-Type Metastatic Colorectal Cancer. Cureus. 14(3). e23543–e23543. 1 indexed citations
3.
Pereira, Fiona, Fátima Carneiro, Alexandra Teixeira, et al.. (2019). Enzalutamide in metastatic castration resistant prostate cancer before chemotherapy. European Urology Supplements. 18(11). e3469–e3469. 1 indexed citations
4.
Sousa, Nuno, C. Faustino, Andreia Capela, et al.. (2019). Homologous recombination deficiency as prognostic marker in metastatic gastric cancer.. Journal of Clinical Oncology. 37(15_suppl). 4040–4040. 3 indexed citations
5.
Afonso, Ana, et al.. (2019). Effectiveness of abiraterone acetate in elderly chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. European Urology Supplements. 18(11). e3471–e3471. 1 indexed citations
6.
Alsina, María, Josep Tabernero, Kohei Shitara, et al.. (2019). Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC).. Journal of Clinical Oncology. 37(15_suppl). 4043–4043. 4 indexed citations
7.
Arkenau, Hendrik‐Tobias, Josep Tabernero, Kohei Shitara, et al.. (2018). TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer. Annals of Oncology. 29. viii718–viii718. 1 indexed citations
9.
Faustino, C., et al.. (2009). Relative dose intensity reduction in breast cancer adjuvant chemotherapy.. Cancer Research. 69(2_Supplement). 4111–4111. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026